Ironwood Pharmaceuticals, Inc. (IRWD)

NASDAQ: IRWD · Real-Time Price · USD

1.010

-0.020 (-1.94%)

At close: Apr 10, 2025, 4:00 PM

0.9981

-0.0120 (-1.17%)

After-hours: Apr 10, 2025, 7:14 PM EDT

Ironwood Pharmaceuticals Income Statement

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	2015 - 2019
Period Ending	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	2015 - 2019
Revenue	351.41	442.74	410.6	413.75	389.52	Upgrade
Revenue Growth (YoY)	-20.63%	7.83%	-0.76%	6.22%	-9.08%	Upgrade
Cost of Revenue	7.55	6.15	4.94	70.41	91.2	Upgrade
Gross Profit	343.86	436.59	405.66	343.35	298.33	Upgrade
Selling, General & Admin	144.27	142.11	115.99	111.13	140	Upgrade
Research & Development	103.87	98.64	39.33	-	-	Upgrade
Operating Expenses	248.14	240.75	155.32	111.13	140	Upgrade
Operating Income	95.72	195.84	250.34	232.22	158.32	Upgrade
Interest Expense	-33.29	-21.38	-7.6	-31.15	-29.48	Upgrade
Interest & Investment Income	4.47	18.97	9.5	0.73	1.5	Upgrade
Other Non Operating Income (Expenses)	0.89	-0.23	0.18	-1.18	-6.11	Upgrade
EBT Excluding Unusual Items	67.79	193.2	252.42	200.61	124.24	Upgrade
Merger & Restructuring Charges	-2.59	-45.82	-	0.04	-15.38	Upgrade
Pretax Income	65.2	-948.07	252.42	200.66	108.86	Upgrade
Income Tax Expense	64.32	83.49	77.36	-327.79	2.69	Upgrade
Earnings From Continuing Operations	0.88	-1,032	175.07	528.45	106.18	Upgrade
Net Income to Company	0.88	-1,032	175.07	528.45	106.18	Upgrade
Minority Interest in Earnings	-	29.32	-	-	-	Upgrade
Net Income	0.88	-1,002	175.07	528.45	106.18	Upgrade
Net Income to Common	0.88	-1,002	175.07	528.45	106.18	Upgrade
Net Income Growth	-	-	-66.87%	397.71%	393.73%	Upgrade
Shares Outstanding (Basic)	159	155	154	162	159	Upgrade
Shares Outstanding (Diluted)	160	155	186	164	161	Upgrade
Shares Change (YoY)	2.99%	-16.57%	13.32%	2.34%	2.97%	Upgrade
EPS (Basic)	0.01	-6.45	1.13	3.26	0.67	Upgrade
EPS (Diluted)	0.01	-6.45	0.96	3.21	0.66	Upgrade
EPS Growth	-	-	-69.98%	386.36%	378.84%	Upgrade
Free Cash Flow	103.41	183.15	273.63	261.63	166.99	Upgrade
Free Cash Flow Per Share	0.65	1.18	1.47	1.59	1.04	Upgrade
Gross Margin	97.85%	98.61%	98.80%	82.98%	76.59%	Upgrade
Operating Margin	27.24%	44.23%	60.97%	56.12%	40.64%	Upgrade
Profit Margin	0.25%	-226.37%	42.64%	127.72%	27.26%	Upgrade
Free Cash Flow Margin	29.43%	41.37%	66.64%	63.23%	42.87%	Upgrade
EBITDA	97.73	197.41	251.76	233.74	160.69	Upgrade
EBITDA Margin	27.81%	44.59%	61.31%	56.49%	41.25%	Upgrade
D&A For EBITDA	2.01	1.58	1.42	1.52	2.36	Upgrade
EBIT	95.72	195.84	250.34	232.22	158.32	Upgrade
EBIT Margin	27.24%	44.23%	60.97%	56.12%	40.64%	Upgrade
Effective Tax Rate	98.65%	-	30.65%	-	2.47%	Upgrade
Revenue as Reported	351.41	442.74	410.6	413.75	389.52	Upgrade

Updated Feb 27, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q